This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
CNBC
cnbc.com
did:plc:m7ks2xhfuku7errrtfjux2lg
Hershey is seeing higher sales for its mints and gum — thanks to the growing use of GLP-1 drugs.
While CEO Kirk Tanner didn’t specify why the increasing usage of GLP-1 agonists fueled mint and gum sales, some people who take the medication report experiencing bad breath. cnb.cx/4n24u8w
2026-04-30T18:30:22.582Z